KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
KMTS lost money over the past year, so it has no meaningful PE right now.
KMTS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
KMTS's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
KMTS PE Valuation
KMTS has no meaningful PE right now: it lost money over the past year.
KMTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect KMTS's revenue to grow, with its earnings and profitability holding steady.
KMTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.68 | +$1.01 |
| Q2 2026 | -$2.43 | +$1.21 |
| Q1 2026 | -$3.96 | -$2.08 |
| Q4 2025 | -$3.85 | -$2.00 |
KMTS lost $2.68 per share over the past year, a smaller loss than the year before.
KMTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $31M | +60% |
| Q2 2026 | $28.6M | +66% |
| Q1 2026 | $24.6M | +63% |
| Q4 2025 | $22.6M | +53% |
| Q3 2025 | $19.4M | +52% |
| Q2 2025 | $17.2M | +71% |
| Q1 2025 | $15.1M | +82% |
KMTS's revenue has grown year over year every quarter since mid-2024: $31M last quarter, up 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -122% | +28 points |
| Q2 2026 | -137% | +142 points |
| Q1 2026 | -142% | -5.1 points |
| Q4 2025 | -141% | -11 points |
| Q3 2025 | -149% | -4.9 points |
| Q2 2025 | -280% | -77 points |
| Q1 2025 | -137% | +105 points |
| Q4 2024 | -130% | N/A |
KMTS's operating margin was −122% last quarter, up 27 points from the same quarter a year ago, near the top of its range since 2024.
KMTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$40.6M | -$6.2M |
| Q2 2026 | -$28.4M | +$3.4M |
| Q1 2026 | -$28.2M | -$5.7M |
| Q4 2025 | -$25.6M | -$2.9M |
| Q3 2025 | -$34.4M | -$9.9M |
| Q2 2025 | -$31.7M | -$12.6M |
| Q1 2025 | -$22.4M | -$1.7M |
| Q3 2021 | -$13.4M | -$7M |
KMTS has burned cash in almost every quarter: −$123M over the past year, against −$111M the year before.
KMTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +8.1% | +4.4M shares |
| 1 year | +14% | +7.3M shares |
| 3 years | +18% | +9M shares |
KMTS has 59M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q3 2021 | — |
| Q3 2020 | — |
KMTS Net Leverage
KMTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
KMTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.3 | Neutral |
| Stochastic | 74.5 | Neutral |
KMTS's weekly RSI is 58 (neutral) and its Stochastic is 74 (neutral).
KMTS PE vs Healthcare Sector
KMTS has no meaningful PE right now: it lost money over the past year.
KMTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.1 | 1.9% above |
| 20 week MA | $26.3 | 8.9% above |
| 50 week MA | $24.2 | 18% above |
KMTS is in an uptrend: it's above all three of its weekly moving averages, and 18% above its 50-week average.
KMTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $21.0 | $27.1 | +29% |
| 2026 YTD | $27.1 | $28.6 | +5.5% |
KMTS has finished every year since 2025 higher, and it's up 5.5% so far in 2026.